MannKind Corp. (MNKD)

5.90 -0.01 (-0.17%) USD  |  NASDAQ  |  Jan 23, 09:39
More

MannKind Research and Development Expense (TTM): 49.90M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for MNKD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Amicus Therapeutics, Inc. 142.29M
Keros Therapeutics, Inc. 157.36M
Moderna, Inc. 3.271B
Vertex Pharmaceuticals, Inc. 3.954B
TG Therapeutics, Inc. 142.90M